Medicine Online
Any medical inquiries? Search MOL for answers:
NEWS
Home > News > 2007 > November > 6 > Cardiac Device Won't Help Some Heart Failure Patients
Medical References
Diseases & Conditions
Women's Health
Mental Health
Men's Health
Healthy Choice News
Site Map Links
Medical Tips
Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news

Cardiac Device Won't Help Some Heart Failure Patients

TUESDAY, Nov. 6 (HealthDay News) -- Heart failure patients treated with a device that synchronizes pumping in the heart''s ventricles showed no improvement in exercise capacity, researchers report.

The results were presented Tuesday at a late-breaking clinical trial session at the American Heart Association''s annual meeting, in Orlando, Fla., and were expected to be published in the Dec. 13 print issue of the New England Journal of Medicine.

Cardiac Resynchronization Therapy (CRT) devices are surgically implanted and deliver electrical impulses to both ventricles at the same time, making both chambers contract simultaneously and thereby improving pumping efficiency.

While current guidelines support using CRT in patients with moderate to severe heart failure, this study aimed to see if the device could benefit patients outside those recommended parameters.

For this trial, 172 heart failure patients were randomly assigned to receive treatment with CRT or not.

Those treated with CRT showed no significant improvement in exercise capacity as measured by peak oxygen consumption. Some symptoms did improve, but quality-of-life scores and results of the six-minute hall walk test did not change significantly, the researchers reported.

"There was no significant difference in the change in peak oxygen consumption between the treatment group and the control group during cardiopulmonary testing," Dr. John Beshai, study lead author and director of pacemaker and defibrillator services in the division of cardiology at the University of Chicago, said at a news conference Tuesday. "Further research is necessary," he said.

The trial was funded by St. Jude Medical, which makes the CRT device.

More information

There''s more on heart failure at the American Heart Association.



-- Amanda Gardner



SOURCES: Nov. 6, 2007, American Heart Association news conference with John Beshai, M.D., director of pacemaker and defibrillator services, division of cardiology, University of Chicago; Dec. 13, 2007, New England Journal of Medicine

Last Updated: Nov. 06, 2007

Copyright © 2007 ScoutNews, LLC. All rights reserved.

HomeSitemap Contact UsAdvertisingPress RoomGive Us Your FeedbackRead Our Terms & Conditions and Our DisclaimerPrivacy Statement